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Vitamin B12/cobalamin functions as an important co-enzyme in the human body and is essential for 
purine and pyrimidine synthesis. Vitamin B12 deficiency is a very well recognized clinical entity but the 
conditions leading to elevated levels of vitamin B12 are generally not; hence the purpose of this article 
is to discuss such etiologies. Understanding the mechanisms will necessitate a brief review of vitamin 
B12 metabolism, presented below.  
 
Under normal physiological conditions, dietary cobalamin binds to haptocorrin (HC) in saliva to be 
transported to the duodenum where free cobalamin is released. The free cobalamin in the duodenum 
binds to intrinsic factor (IF) forming a complex which is taken up by the intestinal mucosa to be 
ultimately released into the circulation. The majority of cobalamin in circulation is bound to 
haptocorrin (HC) and only a small portion (5-20%) is bound to transcobalamin (TC II). The plasma half
-life (t ½) of TC II is short, only 40min-5hrs, whereas it is a long, 6-9 days for HC. When 
transcobalamin passes through enterohepatic circulation it is taken up by the liver for storage and is 
later released into bile.  
 
 
 
 
 
 
 
 
 
 
The reference range for vitamin B12 levels is 200-900 pg/mL (picograms per milliliter) and elevated 
cobalamin levels can be seen in various malignancies including hematological conditions like 
myeloproliferative disorders, renal and liver disorders. 
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Bound protein/form Transcobalamin (TCII)  Haptocorrin (HC) 
Plasma t ½  40min-5hrs 6-9 days 
Site of synthesis Liver, intestine, endothelium Salivary glands, gastric mucosa 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Mechanisms of elevated vitamin B12 levels in the above conditions include: 
 
1.  Excess Haptocorrin production 
Markedly elevated B12 levels (up to 10x!) are often seen with myeloproliferative disorders as listed in 
the table above. The expanded myeloid cell population in myeloproliferative conditions is thought to 
be leading to an increase in HC level thereby causing elevated B12 levels. Elevated B12 levels are also 
more commonly seen in Acute Promyelocytic leukemia (APL) than other types of Acute myeloid 
leukemia (AML).  
 
2.  Release from hepatocytes and reduced uptake 
In cases of acute hepatitis, cirrhosis, HCC or metastatic disease of the liver, pathogenesis is thought to 
be related to both hepatocyte cell injury causing the release of stored vitamin B12 into the circulation 
along with decreased ability of the damaged hepatocytes to take up the circulating vitamin B12. 
 
3.  Excess of transport proteins—both transcobalamin and haptocorrin (TCII and HC) 
In several solid tumors as listed above, excess transport levels were thought to be the culprit for 
elevated B12 levels. The excess transport proteins were both as a result of exogenous production by 
the tumor directly or by the indirect effects of tumor through stimulation of leukocytes to produce 
TCII and HC.   
 
As per this overview, we conclude that a thorough medical investigation is necessary for patients with 
elevated B12 levels including a careful history & physical exam, basic labs including CBC with manual 
differential count, review of peripheral smear and CMP to carefully look at liver function as well as 
further work up as guided by these initial steps. 
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Hematological etiologies 
 
Myeloproliferative conditions  
-Chronic Myeloid Leukemia (CML), Polycythemia Vera (PV), 
Hypereosinophilic syndromes (HES), Chronic myelomonocytic leukemia 
(CMML)  
Myelofibrosis 
Acute Promyelocytic leukemia (APL)- less commonly other types of Acute 
myeloid leukemia (AML) 
  
Malignancy Solid tumors like Hepatocellular carcinoma (HCC), Breast ca, Renal cell ca, 
Colon ca, Gastric ca & any cancer with liver metastases 
 
Hepatic etiologies Hepatitis, Cirrhosis, Hepatocellular carcinoma 
 
Others Chronic kidney disease, Cystic Fibrosis (due to liver injury) & Iatrogenic - 
VitB12 administration 
